Amanda Cashen

Author PubWeight™ 1.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS). Ann Hematol 2011 1.10